Prevalence of drug interactions in hospitalized patients of the internal medicine service of a general hospital of México

Descripción del Articulo

Introduction. The joint prescription of several medications favors the occurrence of drug interactions, reducing the expected effect of the drug, and also favors the appearance of unexpected side effects. Objective. Document the prevalence of drug interactions in patients hospitalized in an internal...

Descripción completa

Detalles Bibliográficos
Autores: Palacios-Rosas, Erika, León-Domínguez, Marla P., Castro-Pastrana, Lucila I.
Formato: artículo
Fecha de Publicación:2021
Institución:Universidad Nacional Mayor de San Marcos
Repositorio:Revistas - Universidad Nacional Mayor de San Marcos
Lenguaje:español
OAI Identifier:oai:ojs.csi.unmsm:article/21176
Enlace del recurso:https://revistasinvestigacion.unmsm.edu.pe/index.php/anales/article/view/21176
Nivel de acceso:acceso abierto
Materia:Interacciones farmacológicas
polifarmacia
farmacovigilancia
hospitalización
Medicina Interna
drug interactions
polypharmacy
pharmacovigilance
hospitalization
internal medicine
id REVUNMSM_33f0454b2b46ed5ab4ea8e4fbe1bc20b
oai_identifier_str oai:ojs.csi.unmsm:article/21176
network_acronym_str REVUNMSM
network_name_str Revistas - Universidad Nacional Mayor de San Marcos
repository_id_str
dc.title.none.fl_str_mv Prevalence of drug interactions in hospitalized patients of the internal medicine service of a general hospital of México
Prevalencia de interacciones farmacológicas en pacientes hospitalizados en el servicio de medicina interna de un hospital general de México
title Prevalence of drug interactions in hospitalized patients of the internal medicine service of a general hospital of México
spellingShingle Prevalence of drug interactions in hospitalized patients of the internal medicine service of a general hospital of México
Palacios-Rosas, Erika
Interacciones farmacológicas
polifarmacia
farmacovigilancia
hospitalización
Medicina Interna
drug interactions
polypharmacy
pharmacovigilance
hospitalization
internal medicine
title_short Prevalence of drug interactions in hospitalized patients of the internal medicine service of a general hospital of México
title_full Prevalence of drug interactions in hospitalized patients of the internal medicine service of a general hospital of México
title_fullStr Prevalence of drug interactions in hospitalized patients of the internal medicine service of a general hospital of México
title_full_unstemmed Prevalence of drug interactions in hospitalized patients of the internal medicine service of a general hospital of México
title_sort Prevalence of drug interactions in hospitalized patients of the internal medicine service of a general hospital of México
dc.creator.none.fl_str_mv Palacios-Rosas, Erika
León-Domínguez, Marla P.
Castro-Pastrana, Lucila I.
Palacios-Rosas, Erika
León-Domínguez, Marla P.
Castro-Pastrana, Lucila I.
author Palacios-Rosas, Erika
author_facet Palacios-Rosas, Erika
León-Domínguez, Marla P.
Castro-Pastrana, Lucila I.
author_role author
author2 León-Domínguez, Marla P.
Castro-Pastrana, Lucila I.
author2_role author
author
dc.subject.none.fl_str_mv Interacciones farmacológicas
polifarmacia
farmacovigilancia
hospitalización
Medicina Interna
drug interactions
polypharmacy
pharmacovigilance
hospitalization
internal medicine
topic Interacciones farmacológicas
polifarmacia
farmacovigilancia
hospitalización
Medicina Interna
drug interactions
polypharmacy
pharmacovigilance
hospitalization
internal medicine
description Introduction. The joint prescription of several medications favors the occurrence of drug interactions, reducing the expected effect of the drug, and also favors the appearance of unexpected side effects. Objective. Document the prevalence of drug interactions in patients hospitalized in an internal medicine department. Methods. Observational, cross-sectional, retrospective study. It analyzed the drug prescriptions using the drugs.com® “Interactions Checker” tool to detect possible drug interactions found in the clinical records of 118 patients hospitalized in an internal medicine department of a public hospital in Mexico. Results. 78% of patients presented at least one drug interaction; 459 interactions were identified in total with a mean of 4 interactions per patient. 75% were classified as moderate, 13.5% mild, and 11.5% severe. Omeprazole had the highest number of interactions, and the most frequent interaction was furosemide + omeprazole. There was a significant relationship between drug interactions and the number of drugs prescribed (p <0.001). Conclusions. There is a high prevalence of possible drug interactions in the study sample, which should be considered when performing a rational prescription process, thereby ensuring the risk-benefit ratio to obtain a far-reaching positive impact on the patients’ health.
publishDate 2021
dc.date.none.fl_str_mv 2021-12-11
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv https://revistasinvestigacion.unmsm.edu.pe/index.php/anales/article/view/21176
10.15381/anales.v82i3.21176
url https://revistasinvestigacion.unmsm.edu.pe/index.php/anales/article/view/21176
identifier_str_mv 10.15381/anales.v82i3.21176
dc.language.none.fl_str_mv spa
language spa
dc.relation.none.fl_str_mv https://revistasinvestigacion.unmsm.edu.pe/index.php/anales/article/view/21176/17394
dc.rights.none.fl_str_mv Derechos de autor 2021 Anales de la Facultad de Medicina
http://creativecommons.org/licenses/by-nc-sa/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Derechos de autor 2021 Anales de la Facultad de Medicina
http://creativecommons.org/licenses/by-nc-sa/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidad Nacional Mayor de San Marcos, Facultad de Medicina Humana
publisher.none.fl_str_mv Universidad Nacional Mayor de San Marcos, Facultad de Medicina Humana
dc.source.none.fl_str_mv Anales de la Facultad de Medicina; Vol. 82 No. 3 (2021)
Anales de la Facultad de Medicina; Vol. 82 Núm. 3 (2021)
1609-9419
1025-5583
reponame:Revistas - Universidad Nacional Mayor de San Marcos
instname:Universidad Nacional Mayor de San Marcos
instacron:UNMSM
instname_str Universidad Nacional Mayor de San Marcos
instacron_str UNMSM
institution UNMSM
reponame_str Revistas - Universidad Nacional Mayor de San Marcos
collection Revistas - Universidad Nacional Mayor de San Marcos
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1795238259221069824
spelling Prevalence of drug interactions in hospitalized patients of the internal medicine service of a general hospital of MéxicoPrevalencia de interacciones farmacológicas en pacientes hospitalizados en el servicio de medicina interna de un hospital general de MéxicoPalacios-Rosas, ErikaLeón-Domínguez, Marla P.Castro-Pastrana, Lucila I.Palacios-Rosas, ErikaLeón-Domínguez, Marla P.Castro-Pastrana, Lucila I.Interacciones farmacológicaspolifarmaciafarmacovigilanciahospitalizaciónMedicina Internadrug interactionspolypharmacypharmacovigilancehospitalizationinternal medicineIntroduction. The joint prescription of several medications favors the occurrence of drug interactions, reducing the expected effect of the drug, and also favors the appearance of unexpected side effects. Objective. Document the prevalence of drug interactions in patients hospitalized in an internal medicine department. Methods. Observational, cross-sectional, retrospective study. It analyzed the drug prescriptions using the drugs.com® “Interactions Checker” tool to detect possible drug interactions found in the clinical records of 118 patients hospitalized in an internal medicine department of a public hospital in Mexico. Results. 78% of patients presented at least one drug interaction; 459 interactions were identified in total with a mean of 4 interactions per patient. 75% were classified as moderate, 13.5% mild, and 11.5% severe. Omeprazole had the highest number of interactions, and the most frequent interaction was furosemide + omeprazole. There was a significant relationship between drug interactions and the number of drugs prescribed (p <0.001). Conclusions. There is a high prevalence of possible drug interactions in the study sample, which should be considered when performing a rational prescription process, thereby ensuring the risk-benefit ratio to obtain a far-reaching positive impact on the patients’ health.Introducción. Los medicamentos han logrado prolongar y mejorar la calidad de vida de los pacientes, pero no garantizan estar libres de riesgo. La prescripción conjunta de varios medicamentos favorece que existan interacciones farmacológicas, disminuyendo el efecto esperado del medicamento y favoreciendo la aparición de efectos secundarios inesperados que ponen en peligro la vida del paciente. Objetivo. Determinar la prevalencia de interacciones farmacológicas en pacientes hospitalizados en un servicio de medicina interna de un hospital general. Métodos. Estudio observacional, transversal y retrospectivo. Se analizaron las prescripciones farmacológicas, utilizando la herramienta “Interactions Checker” de drugs. com® para la detección de posibles interacciones farmacológicas encontradas en los expedientes clínicos de 118 pacientes hospitalizados en un servicio de medicina interna de un hospital público de México. Resultados. El 78% de los pacientes presentaron al menos una interacción farmacológica, se identificaron 459 interacciones en total con una media de 4 interacciones por paciente. El 75% fueron de clasificación moderada, 13,5% leves y 11,5% graves. El omeprazol presentó el mayor número de interacciones y la interacción con mayor frecuencia fue furosemide + omeprazol. Se encontró una relación significativa entre las interacciones farmacológicas y el número de fármacos prescritos (p <0,001). Conclusiones. Existe una alta prevalencia de posibles interacciones farmacológicas en nuestra muestra de estudio, éstas deben ser consideradas para realizar un proceso de prescripción racional, asegurando la relación riesgo-beneficio para obtener un impacto positivo de gran alcance en la salud de los pacientes.Universidad Nacional Mayor de San Marcos, Facultad de Medicina Humana2021-12-11info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://revistasinvestigacion.unmsm.edu.pe/index.php/anales/article/view/2117610.15381/anales.v82i3.21176Anales de la Facultad de Medicina; Vol. 82 No. 3 (2021)Anales de la Facultad de Medicina; Vol. 82 Núm. 3 (2021)1609-94191025-5583reponame:Revistas - Universidad Nacional Mayor de San Marcosinstname:Universidad Nacional Mayor de San Marcosinstacron:UNMSMspahttps://revistasinvestigacion.unmsm.edu.pe/index.php/anales/article/view/21176/17394Derechos de autor 2021 Anales de la Facultad de Medicinahttp://creativecommons.org/licenses/by-nc-sa/4.0info:eu-repo/semantics/openAccessoai:ojs.csi.unmsm:article/211762021-12-27T16:30:55Z
score 13.7211075
Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).